Subsection 3: Medicinal products covered by an early access authorisation or a compassionate access authorisation

I.-The labelling of the medicinal products mentioned in 1° of II of article L. 5121-12 includes at least the following information: 1° The name of the medicinal product or, where appropriate, its code name or international non-proprietary name; 2° The name or corporate name and address of the company manufacturing the medicinal product; 3° The batch number; 4° The route and, if applicable, the method of administration of the medicinal…

The labelling of the medicinal products mentioned in II of article L. 5121-12-1 includes at least the following information: 1° The name of the medicinal product or, where appropriate, its code name or international non-proprietary name; 2° The name or business name and address of the company; 3° The batch number; 4° The route and, where appropriate, the method of administration of the medicinal product; 5° The expiry date; 6°…